IL-10/IFN-gamma lipopeptide inhibitors (NCI)

N/A

Report date: 2025/03/20 15:51:40

Base Information

Drug NameIL-10/IFN-gamma lipopeptide inhibitors (NCI)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionInterferon gamma receptor antagonistsInterleukin 10 receptor inhibitors
TargetsInterleukin 10 receptorInterferon gamma receptor
Therapy Area/IndicationsInflammationNeoplasmsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthNational Cancer Institute
Inactive CompaniesN/A
Active IndicationsInflammationNeoplasmsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A